A phase II safety and efficacy study of amprenavir in combination with zidovudine and lamivudine in HIV-infected patients with limited antiretroviral experience. Amprenavir PROAB2002 Study Team.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples